Others

Granules India’s Gagillapur facility successfully completed US FDA inspection

| Updated on October 17, 2016 Published on October 17, 2016

Granules India Ltd has informed BSE that Company’s Gagillapur facility located at Hyderabad, Telangana, India has successfully completed US FDA inspection without any observations. This facility manufactures Finished Dosages (FDs) and Pharmaceutical Formulation Intermediates (PFIs).

Pdf Link: >Granules India’s Gagillapur facility successfully completed US FDA inspection

Source : BSE - >www.bseindia.com

Published on October 17, 2016
This article is closed for comments.
Please Email the Editor